Artwork

İçerik Office of the Vice-Dean Research, College of Medicine, University of Saskatchewan., University of Saskatchewan, OVDR, and College of Medicine tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan Office of the Vice-Dean Research, College of Medicine, University of Saskatchewan., University of Saskatchewan, OVDR, and College of Medicine veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.
Player FM - Podcast Uygulaması
Player FM uygulamasıyla çevrimdışı Player FM !

Triple Negative Breast Cancer: Chandra Dattani's Story

27:09
 
Paylaş
 

Manage episode 326440966 series 2876289
İçerik Office of the Vice-Dean Research, College of Medicine, University of Saskatchewan., University of Saskatchewan, OVDR, and College of Medicine tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan Office of the Vice-Dean Research, College of Medicine, University of Saskatchewan., University of Saskatchewan, OVDR, and College of Medicine veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.

Chandra Dattani's smile lit up the room, and her laughter was contagious.

But when the beloved Saskatoon businesswoman and volunteer was diagnosed with triple negative breast cancer, even her husband, a physician, found very little information about therapies or drugs that could heal her.

"There was very scant literature on triple negative, and I was asking them, why?" said Dr. Dan Dattani.

Typically, oncology teams target estrogen and progesterone receptors to stop breast cancer tumours from growing and spreading.

Unfortunately, those targets don't work for the 15 to 20 per cent of breast cancer patients with triple negative breast cancer, a swift-moving and aggressive form of the disease.

Still, Chandra Dattani and her family decided to fight back.

They established the Chandra Dattani Memorial Fund in 2010. It's currently endowed with a balance of over 120 thousand dollars, and continues to support critical cancer research on an annual basis.

"She was so dedicated to making sure we'd never gave up on ourselves and was really our biggest cheerleader every step of the way," said Seema Jain, Dattani's eldest daugher.

In this episode, Jain joins her siblings and her father in unraveling her mother's story, and pushing for more research and therapies dedicated to women with a triple negative diagnosis.

"Our biggest hope is hopefully women won't have to suffer the way our mom did," said Dr. Sheev Dattani.

"Hopefully there will be better treatments coming down the road."

  continue reading

87 bölüm

Artwork
iconPaylaş
 
Manage episode 326440966 series 2876289
İçerik Office of the Vice-Dean Research, College of Medicine, University of Saskatchewan., University of Saskatchewan, OVDR, and College of Medicine tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan Office of the Vice-Dean Research, College of Medicine, University of Saskatchewan., University of Saskatchewan, OVDR, and College of Medicine veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.

Chandra Dattani's smile lit up the room, and her laughter was contagious.

But when the beloved Saskatoon businesswoman and volunteer was diagnosed with triple negative breast cancer, even her husband, a physician, found very little information about therapies or drugs that could heal her.

"There was very scant literature on triple negative, and I was asking them, why?" said Dr. Dan Dattani.

Typically, oncology teams target estrogen and progesterone receptors to stop breast cancer tumours from growing and spreading.

Unfortunately, those targets don't work for the 15 to 20 per cent of breast cancer patients with triple negative breast cancer, a swift-moving and aggressive form of the disease.

Still, Chandra Dattani and her family decided to fight back.

They established the Chandra Dattani Memorial Fund in 2010. It's currently endowed with a balance of over 120 thousand dollars, and continues to support critical cancer research on an annual basis.

"She was so dedicated to making sure we'd never gave up on ourselves and was really our biggest cheerleader every step of the way," said Seema Jain, Dattani's eldest daugher.

In this episode, Jain joins her siblings and her father in unraveling her mother's story, and pushing for more research and therapies dedicated to women with a triple negative diagnosis.

"Our biggest hope is hopefully women won't have to suffer the way our mom did," said Dr. Sheev Dattani.

"Hopefully there will be better treatments coming down the road."

  continue reading

87 bölüm

Tüm bölümler

×
 
Loading …

Player FM'e Hoş Geldiniz!

Player FM şu anda sizin için internetteki yüksek kalitedeki podcast'leri arıyor. En iyi podcast uygulaması ve Android, iPhone ve internet üzerinde çalışıyor. Aboneliklerinizi cihazlar arasında eş zamanlamak için üye olun.

 

Hızlı referans rehberi

Keşfederken bu şovu dinleyin
Çal